I. Johannessen et al., Essential role for T cells in human B-cell lymphoproliferative disease development in severe combined immunodeficient mice, BR J HAEM, 109(3), 2000, pp. 600-610
Epstein-Barr virus (EBV)-positive B-cell lymphoproliferative disease (BLPD)
-like lesions develop in severe combined immunodeficient (SCID) mice inocul
ated with peripheral blood mononuclear cells (PBMCs) from EBV-seropositive
donors, We used this model to investigate the pathogenesis of EBV-associate
d BLPD. Tumour incidence fell from 81% to 11% when only B cells were inocul
ated, suggesting a key role for T cells in tumour formation. This was furth
er underlined by the reduction in tumour incidence from 76% to 7% when PBMC
s were depleted of CD4 positive (+ve) helper T cells. Tumour outgrowth was
also reduced when PBMC were depleted of CD8 +ve, CD45RA +ve or CD45RO +ve T
cells. The majority of PBMC-derived tumours analysed by reverse transcript
ase-polymerase chain reaction (RT-PCR) expressed mRNA for interleukin (IL)
2, 4, 6, 10 and interferon (IFN) gamma. This is the cytokine pattern seen i
n activated T cells and includes B-cell growth factors. III situ hybridizat
ion studies confirmed that the tumour cells themselves express the growth f
actors. which is consistent with autocrine-stimulated tumour growth.
Our results suggest the following sequence of events: (1) T cells are essen
tial for the initial outgrowth of tumorigenic EBV +ve B cells in vivo; (2)
the neoplasm sustains its growth in an autocrine, cytokine-stimulated manne
r; and (3) established tumours become independent of T-cell help.